Procurement Summary
Country: Albania
Summary: Lot 109 Rituximab Biosimilar or Originator
Deadline: 29 Jun 2026
Posting Date: 28 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142207610
Document Ref. No.: REF-87328-05-26-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: ALL 176756517.00
CPV Classification
33652100 - Antineoplastic agents
33661000 - Medicinal products for the nervous system
33662000 - Medicinal products for sensory organs
33670000 - Medicinal products for the respiratory system
33696800 - X-ray contrast media
33610000 - Medicinal products for the alimentary tract and metabolism
33612000 - Medicinal products for functional gastrointestinal disorders
33622000 - Medicinal products for the cardiovascular system
33631000 - Medicinal products for dermatology
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Lot 109 Rituximab Biosimilar or originator CPV: 33652100-6 - Antineoplastic agents notice_number : CN/11851/05262026
Open_Date:28-05-2026 Close_Date:29-06-2026
Documents
Tender Notice
2-PV-Shqip-kritere-B1-barna-2026-2028.docx